Metformin "Teva B.V." 500 mg filmovertrukne tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

metformin "teva b.v." 500 mg filmovertrukne tabletter

teva b.v. - metforminhydrochlorid - filmovertrukne tabletter - 500 mg

Orserdu Evrópusambandið - danska - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Camzyos Evrópusambandið - danska - EMA (European Medicines Agency)

camzyos

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - andre hjertepræparater - treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Zejula Evrópusambandið - danska - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Quviviq Evrópusambandið - danska - EMA (European Medicines Agency)

quviviq

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - søvninitierings- og vedligeholdelsesforstyrrelser - psykoleptika - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

Campto 20 mg/ml koncentrat til infusionsvæske, opløsning Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

campto 20 mg/ml koncentrat til infusionsvæske, opløsning

pfizer aps - irinotecanhydrochloridtrihydrat - koncentrat til infusionsvæske, opløsning - 20 mg/ml

Irinotecan "Actavis" 20 mg/ml koncentrat til infusionsvæske, opløsning Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

irinotecan "actavis" 20 mg/ml koncentrat til infusionsvæske, opløsning

actavis group ptc ehf. - irinotecanhydrochloridtrihydrat - koncentrat til infusionsvæske, opløsning - 20 mg/ml

Irinotecan "Sun" 1,5 mg/ml infusionsvæske, opløsning Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

irinotecan "sun" 1,5 mg/ml infusionsvæske, opløsning

sun pharmaceutical industries europe bv - irinotecanhydrochloridtrihydrat - infusionsvæske, opløsning - 1,5 mg/ml

Advagraf Evrópusambandið - danska - EMA (European Medicines Agency)

advagraf

astellas pharma europe bv - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantationsafstødning hos voksne nyre- eller levertransplantationsmodtagere. behandling af allograft afvisning resistente over for behandling med andre immunosuppressive lægemidler hos voksne patienter.

Envarsus Evrópusambandið - danska - EMA (European Medicines Agency)

envarsus

chiesi farmaceutici s.p.a. - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantationsafstødning hos voksne nyre- eller levertransplantationsmodtagere. behandling af allograft afvisning resistente over for behandling med andre immunosuppressive lægemidler hos voksne patienter.